Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. It launched its first test, Oncotype DX, which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The Oncotype DX assay represents the first diagnostic gene expression test on the market that provides consistent results across multiple independent trials having breast cancer patients, including a large validation study of The New England Journal of Medicine. Genomic Health Inc. has a market cap of $573.5 million; its shares were traded at around $20.08 with and P/S ratio of 5.2.
Insiders' Positions with GHDX
- Sell:: President and CEO Kimberly J Popovits sold 5,000 shares of GHDX stock on 10/15/2009 at the average price of 20.42, the price of the stock has decreased by 1.67% since
- Sell:: President and CEO Kimberly J Popovits sold 5,000 shares of GHDX stock on 09/15/2009 at the average price of 20.73, the price of the stock has decreased by 3.14% since
- Sell:: President and CEO Kimberly J Popovits sold 5,000 shares of GHDX stock on 08/17/2009 at the average price of 19.53, the price of the stock has increased by 2.82% since
Insiders' Positions with GHDX
- Sell:: COO & CFO G Bradley Cole sold 5,000 shares of GHDX stock on 08/13/2009 at the average price of 20, the price of the stock has increased by 0.4% since
Insiders' Positions with GHDX
- Buy:: Director, 10% Owner Biotech Capital (gp), Ll Baker bought 11,657 shares of GHDX stock on 08/17/2009 at the average price of 19.98, the price of the stock has increased by 0.5% since
- Buy:: Director, 10% Owner Bros. Capital (gp), Llc Baker bought 34 shares of GHDX stock on 08/17/2009 at the average price of 19.98, the price of the stock has increased by 0.5% since
- Buy:: Director, 10% Owner Brothers Life Sciences C Baker bought 66,630 shares of GHDX stock on 08/17/2009 at the average price of 19.98, the price of the stock has increased by 0.5% since
- Buy:: Director, 10% Owner Capital (gp), Llc 14159 bought 1,839 shares of GHDX stock on 08/17/2009 at the average price of 19.98, the price of the stock has increased by 0.5% since
- Buy:: Director, 10% Owner Brothers Life Sciences C Baker bought 90,754 shares of GHDX stock on 08/12/2009 at the average price of 19.49, the price of the stock has increased by 3.03% since
Rate This Article: |
  |